These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8856089)

  • 1. Effects of combinations of stem cell factor and hemin on erythropoiesis after azidothymidine treatment of immunosuppressed mice.
    Hamburger AW
    Eur J Haematol; 1996 Aug; 57(2):128-33. PubMed ID: 8856089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amelioration of azidothymidine-induced erythroid toxicity by hemin and stem cell factor in immune-suppressed mice.
    Hamburger AW; Chen RB
    Exp Hematol; 1994 Apr; 22(4):348-52. PubMed ID: 7512046
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of stem cell factor to ameliorate AZT-induced anemia in immunodeficient mice.
    Hamburger AW; Zsebo K; Chow FP
    Eur J Haematol; 1993 Mar; 50(3):172-8. PubMed ID: 7682517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of in vivo administration of stem cell factor on thrombopoiesis in normal and immunodeficient mice.
    Chow FP; Zsebo K; Hamburger AW
    Exp Hematol; 1993 Aug; 21(9):1255-62. PubMed ID: 7687220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time-dependent changes induced by azidothymidine in erythroid progenitor colonies in immunodeficient mice.
    Chow FP; Hamburger AW
    Exp Hematol; 1992 Feb; 20(2):245-50. PubMed ID: 1544395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combination interleukin-3 (IL-3) and granulocyte-macrophage colony stimulating factor (GM-CSF) on hematopoiesis administered to retrovirus-infected immunodeficient mice receiving dose-escalation zidovudine (AZT).
    Gallicchio VS; Hughes NK; Tse KF; Ling J; Gaines H; Bowen TE; Uluitu M
    Int J Immunopharmacol; 1995 Nov; 17(11):865-78. PubMed ID: 8788116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microenvironmental toxicity of azidothymidine: partial sparing with hemin.
    Abraham NG; Bucher D; Niranjan U; Brown AC; Lutton JD; Distenfeld A; Ahmed T; Levere RD
    Blood; 1989 Jul; 74(1):139-44. PubMed ID: 2752105
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sensitivity of erythroid progenitor colonies to erythropoietin in azidothymidine treated immunodeficient mice.
    Chow FP; Sutton PA; Hamburger AW
    Br J Haematol; 1991 Feb; 77(2):139-44. PubMed ID: 2004015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained elevation of platelet counts by long-term azidothymidine treatment of immunosuppressed mice.
    Chow FP; Chen RB; Hamburger AW
    J Lab Clin Med; 1993 Apr; 121(4):562-9. PubMed ID: 8454938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Failure to establish long-term marrow cultures from immunodeficient mice (MAIDS): effect of zidovudine in vitro.
    Tse KF; Hughes NK; Gallicchio VS
    J Leukoc Biol; 1993 Jun; 53(6):658-65. PubMed ID: 8315348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo evaluation of the anemia induced by azidothymidine (AZT) in a murine model of AIDS.
    Chow FP; Hamburger AW
    Eur J Haematol; 1991 Aug; 47(2):91-7. PubMed ID: 1889487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of megakaryocyte colony forming cell numbers and ploidy by dideoxynucleosides in immunodeficient mice.
    Chow FP; Ordóñez JV; Sutton PA; Hamburger AW
    Am J Hematol; 1993 Dec; 44(4):249-55. PubMed ID: 8237995
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sustained zidovudine treatment on hematopoiesis in immunodeficient mice.
    Gallicchio VS; Hughes NK; Tse KF
    Int J Immunopharmacol; 1993 Aug; 15(6):673-81. PubMed ID: 8407052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hemopoietic recovery from AZT toxicity with recombinant hemoglobin in a murine model of AIDS.
    Moqattash S; Lutton JD; Abu-Hijleh MF; Abraham NG
    Acta Haematol; 1994; 92(4):182-6. PubMed ID: 7701915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impaired ability of bone marrow cells from immunodeficient mice to establish long-term cultures.
    Hamburger AW; Chen RB
    Br J Haematol; 1993 Dec; 85(4):646-52. PubMed ID: 7918027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of blood substitute, recombinant hemoglobin, on in vivo hematopoietic recovery from AZT toxicity.
    Moqattash S; Lutton JD; Rosenthal G; Abu-Hijleh MF; Abraham NG
    Acta Haematol; 1997; 98(2):76-82. PubMed ID: 9286303
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effect of erythropoietin and heme on murine hematopoietic recovery after azidothymidine treatment.
    Harrison J; Kappas A; Levere RD; Lutton JD; Chertkov JL; Jiang S; Abraham NG
    Blood; 1993 Dec; 82(12):3574-9. PubMed ID: 8260696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term bone marrow stromal and hemopoietic toxicity to AZT: protective role of heme and IL-1.
    Abraham NG; Chertkov JL; Staudinger R; Jiang S; Lutton JD; Argani I; Levere RD; Kappas A
    Exp Hematol; 1993 Feb; 21(2):263-8. PubMed ID: 7678812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of interleukin-1, GM-CSF, erythropoietin, and lithium on the toxicity associated with 3'-azido-3'-deoxythymidine (AZT) in vitro on hematopoietic progenitors (CFU-GM, CFU-MEG, and BFU-E) using murine retrovirus-infected hematopoietic cells.
    Gallicchio VS; Hughes NK; Hulette BC; Noblitt L
    J Leukoc Biol; 1991 Dec; 50(6):580-6. PubMed ID: 1940611
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute toxic effects of 3'-azido-3'-deoxythymidine (AZT) on normal and regenerating murine hematopoiesis.
    Scheding S; Media JE; Nakeff A
    Exp Hematol; 1994 Jan; 22(1):60-5. PubMed ID: 8282060
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.